Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Syndax Pharmaceuticals Inc (SNDX)  
$21.75 0.22 (1%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 94,014,000
Market Cap: 2.04(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.39 - $24.57
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of cancer therapies. Co.'s two primary product candidates are, SNDX-5613 and SNDX-6352 or axatilimab. Co. is developing SNDX-5613, targeting the binding interaction of menin with the mixed lineage leukemia 1 (MLL1) protein for the treatment of MLL-rearranged acute leukemias and nucleophosmin 1 mutant acute myeloid leukemia, as well as axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 receptor. Co. has a collaboration and license agreement with Incyte Corporation for the development and commercialization of axatilimab.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 242,142 1,322,814
Total Sell Value $0 $0 $4,873,574 $30,131,894
Total People Sold 0 0 3 8
Total Sell Transactions 0 0 5 37
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 208
  Page 3 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Metzger Michael A Chief Executive Officer   •       •      –    2022-10-06 4 OE $8.77 $142,346 D/D 16,231 33,890     -
   Katkin Keith   –       •      –    2022-10-06 4 AS $25.90 $774,411 D/D (29,899) 32,000 -0%     
   Katkin Keith   –       •      –    2022-10-06 4 OE $7.88 $245,177 D/D 29,899 41,117     -
   Metzger Michael A Chief Executive Officer   •       •      –    2022-10-04 4 AS $25.02 $32,026 D/D (1,280) 17,659 4%     
   Metzger Michael A Chief Executive Officer   •       •      –    2022-10-04 4 OE $8.77 $11,226 D/D 1,280 18,939     -
   Katkin Keith   –       •      –    2022-10-04 4 AS $25.00 $9,000 D/D (360) 32,000 4%     
   Katkin Keith   –       •      –    2022-10-04 4 OE $7.88 $3,071 D/D 360 32,223     -
   Metzger Michael A Chief Executive Officer   •       •      –    2022-10-03 4 AS $25.01 $72,107 D/D (2,883) 17,659 9%     
   Metzger Michael A Chief Executive Officer   •       •      –    2022-10-03 4 OE $8.77 $25,284 D/D 2,883 20,542     -
   Katkin Keith   –       •      –    2022-10-03 4 AS $25.00 $4,500 D/D (180) 32,000 9%     
   Katkin Keith   –       •      –    2022-10-03 4 OE $7.88 $1,432 D/D 180 32,013     -
   Metzger Michael A Chief Executive Officer   •       •      –    2022-09-30 4 AS $25.02 $740,757 D/D (29,606) 17,659 7%     
   Metzger Michael A Chief Executive Officer   •       •      –    2022-09-30 4 OE $8.77 $259,645 D/D 29,606 47,265     -
   Katkin Keith   –       •      –    2022-09-30 4 AS $25.07 $89,277 D/D (3,561) 32,000 7%     
   Katkin Keith   –       •      –    2022-09-30 4 OE $7.88 $28,740 D/D 3,561 32,647     -
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-20 4 AS $23.25 $1,387,012 D/D (59,649) 17,836 22%     
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-20 4 OE $10.90 $650,174 D/D 59,649 77,485     -
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-19 4 AS $23.03 $2,633,044 D/D (114,339) 17,836 25%     
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-19 4 OE $10.90 $1,246,295 D/D 114,339 132,175     -
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-16 4 AS $23.22 $2,902,438 D/D (125,000) 17,836 17%     
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-16 4 OE $7.20 $1,096,226 D/D 125,000 70,870     -
   Podlesak Dennis   –       •      –    2022-09-16 4 AS $23.43 $280,607 D/D (11,975) 75,763 17%     
   Podlesak Dennis   –       •      –    2022-09-16 4 OE $6.32 $75,879 D/D 11,975 82,319     -
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-15 4 AS $24.20 $1,616,035 D/D (66,775) 17,836 15%     
   Morrison Briggs President, Head of R&D   •       •      –    2022-09-15 4 OE $7.20 $480,780 D/D 66,775 84,611     -
  208 Records found
  1  2  3  4  5  6  7  8  9   
  Page 3 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us